[1] YANG S, LIN Q, LIN W, et al. Effect of adjuvant interferontherapy on hepatitis B virus-related hepatocellular carcino-ma:A systematic review[J]. World J Surg Oncol, 2016, 14 (1) :159.
|
[2] SHI J, SHEN Z, MIAO H, et al. Association between serumlipid levels and antiviral treatment outcome inpatients with chro-nic hepatitis[J]. J Clin Hepatol, 2014, 30 (6) :496-500. (inChinese) 时佳, 沈震, 苗慧, 等.血脂水平与慢性丙型肝炎患者抗病毒疗效的相关性分析[J].临床肝胆病杂志, 2014, 30 (6) :496-500.
|
[3] ABBASI A, BHUTTO AR, BUTT N, et al. Serum cholesterol:Could it be a sixth parameter of Child-Pugh scoring system incirrhotics due to viral hepatitis?[J]. J Coll Physicians SurgPak, 2012, 22 (8) :484-487.
|
[4] WANG CC, TSENG TC, KAO JH. Hepatitis B virus infectionand metabolic syndrome:Fact or fiction?[J]. J Gastroen-terol Hepatol, 2015, 30 (1) :14-20.
|
[5] NAU AL, SOARES JC, SHIOZAWA MB, et al. Clinical and la-boratory characteristics associated with dyslipidemia and liversteatosis in chronic HBV carriers[J]. Rev Soc Bras Med Trop, 2014, 47 (2) :158-164.
|
[6] JOHNSON PJ, BERHANE S, KAGEBAYASHI C, et al. As-sessment of liver function in patients with hepatocellular carci-noma:A new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33 (6) :550-558.
|
[7] BO C, SHA L. Albumin-bilirubin (ALBI) score at admissionpredicts possible outcomes in patients with acute-on-chron-ic liver failure[J]. Medicine, 2017, 96 (24) :e7142.
|
[8] Chinese Society of Hepatology and Chinese Society of Infec-tious Diseases, Chinese Medical Association. The guidelinesof prevention and treatment for chronic hepatitis B:A 2015 Up-date[J]. J Clin Hepatol, 2015, 31 (12) :1941-1960. (inChinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
[9] ZHANG C, GONG L, CHEN Y, et al. A human-derived pro-tein SBP (HBsAg-binding protein) can bind to hepatitis B vi-rus surface antigen (HBs Ag) and enhance the immune re-sponse to hepatitis B virus (HBV) vaccine[J]. Mol Immunol, 2013, 53 (1-2) :60-71.
|
[10] VERE CC, NEAGOE D, STREBA CT, et al. Steatosis and ser-um lipid patterns in patients with chronic viral hepatitis:Differ-ences related to viral etiology[J]. Rom J Morphol Embryol, 2010, 51 (3) :509-514.
|
[11] ARAIN SQ, TALPUR FN, CHANNA NA, et al. Serum lipids asan indicator for the alteration of liver function in patients withhepatitis B[J]. Lipids Health Dis, 2018, 17 (1) :36.
|
[12] WU T, ZHENG X, YANG M, et al. Serum lipid alterations iden-tified in chronic hepatitis B, hepatitis B virus-associated cir-rhosis and carcinoma patients[J]. Sci Rep, 2017, 7:42710.
|
[13] GHADIR MR, RIAHIN AA, HAVASPOUR A, et al. The relation-ship between lipid profile and severity of liver damage in cir-rhotic patients[J]. Hepat Mon, 2010, 10 (4) :285-288.
|
[14] BASSANI L, FERNANDES SA, RAIMUNDO FV, et al. Lipidprofile of cirrhotic patients and its association with prognosticscores:A cross-sectional study[J]. Arq Gastroenterol, 2015, 52 (3) :210.
|
[15] CHEN RC, CAI YJ, WU JM, et al. Usefulness of albumin-biliru-bin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis[J]. J Viral Hepat, 2017, 24 (13) :238-245.
|